We are delighted to announce the acquisition of DGr Pharma, an internationally operating consultancy and contract research organization (CRO) headquartered in Breda, the Netherlands.
DGr Pharma specializes in preclinical and clinical regulatory strategy and consultancy for biotech and pharmaceutical partners working in early drug development. Its core services include chemical-pharmaceutical, non-clinical and clinical development planning, quality assurance, and regulatory submissions. DGr Pharma has deep expertise in small and large molecules including antibodies, ADCs, and oligonucleotides.
Their broad service offering includes:
- Project Management: coordinating everything from individual trials to full development programs.
- Non-clinical Development: planning and managing non-clinical studies to support progression into the clinic.
- Clinical Development – Consultancy: providing strategic and operational guidance for clinical studies.
- Pharmacokinetics – Data Analysis: delivering expert analysis of drug concentration–time data across all development stages.
- CMC Services: ensuring robust Chemistry, Manufacturing and Control (CMC) to support development and regulatory submissions.
- Regulatory Affairs: navigating global requirements with tailored regulatory strategies and hands-on support.
- Quality Assurance (QA): maintaining compliance and high-quality standards across development and operations.
- IT and Data Storage: safeguarding critical development data with secure, reliable infrastructure.
With this acquisition, we are extending our support further along the development pathway. By adding DGr Pharma’s consultancy and regulatory expertise to our integrated offering, we strengthen our ability to guide clients seamlessly from early discovery through development, registration, and manufacturing.
This partnership reflects our ongoing commitment to building a truly end-to-end service model. Together with DGr Pharma, we will be able to offer even greater flexibility, scientific depth, and speed, helping our clients bring high-quality medicines to patients worldwide.
We look forward to working closely with our new colleagues and building the next chapter of Symeres together.
